HOME_PAGE_HEADER_CONTENT
Learn More-HP Updated
Learn More
Featured News
Press Releases
Fri Jun 28 00:00:00 GMT-05:00 2024
Arbitration Dispute Between Daiichi Sankyo and Seagen Ends
Download
Wed Jun 26 00:00:00 GMT-05:00 2024
Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer
Download
Sun Jun 02 00:00:00 GMT-05:00 2024
ENHERTU® Demonstrated a Median Progression-Free Survival of 13.2 Months in HR Positive, HER2 Low and HER2 Ultralow Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy
Download